These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 28582566)
1. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566 [TBL] [Abstract][Full Text] [Related]
2. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. Pignatelli D Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. Escobar-Morreale HF; Sanchón R; San Millán JL J Clin Endocrinol Metab; 2008 Feb; 93(2):527-33. PubMed ID: 18000084 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism. Grodnitskaya E; Kurtser M Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219 [TBL] [Abstract][Full Text] [Related]
6. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Moran C; Azziz R Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women. Fanta M; Cibula D; Vrbíková J Gynecol Endocrinol; 2008 Mar; 24(3):154-7. PubMed ID: 18335331 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Unluhizarci K; Kula M; Dundar M; Tanriverdi F; Israel S; Colak R; Dokmetas HS; Atmaca H; Bahceci M; Balci MK; Comlekci A; Bilen H; Akarsu E; Erem C; Kelestimur F Gynecol Endocrinol; 2010 Feb; 26(2):139-43. PubMed ID: 19718570 [TBL] [Abstract][Full Text] [Related]
9. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone. Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851 [TBL] [Abstract][Full Text] [Related]
10. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Falhammar H; Nordenström A Endocrine; 2015 Sep; 50(1):32-50. PubMed ID: 26082286 [TBL] [Abstract][Full Text] [Related]
15. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Moran C; Azziz R; Weintrob N; Witchel SF; Rohmer V; Dewailly D; Marcondes JA; Pugeat M; Speiser PW; Pignatelli D; Mendonca BB; Bachega TA; Escobar-Morreale HF; Carmina E; Fruzzetti F; Kelestimur F J Clin Endocrinol Metab; 2006 Sep; 91(9):3451-6. PubMed ID: 16822826 [TBL] [Abstract][Full Text] [Related]
16. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH). Chanukvadze D; Kristesashvili J; Kvashilava N Iran J Reprod Med; 2012 Jul; 10(4):307-14. PubMed ID: 25246891 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea. Binay C; Simsek E; Cilingir O; Yuksel Z; Kutlay O; Artan S Int J Endocrinol; 2014; 2014():768506. PubMed ID: 24778650 [TBL] [Abstract][Full Text] [Related]
18. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency. Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247 [TBL] [Abstract][Full Text] [Related]
20. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Nordenström A; Falhammar H Eur J Endocrinol; 2019 Mar; 180(3):R127-R145. PubMed ID: 30566904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]